Mode
Text Size
Log in / Sign up
N/A N=45 Treatment

A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

Acne Vulgaris

Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcome: Primary: Cutaneous Tolerance Scores: Erythema — -0.07 Units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Acne Mask (Device)
Age
Pediatric, Adult · 12+ yrs
Sex
All
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Primary completion
Jun 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Cutaneous Tolerance Scores: Erythema
-0.09
PRIMARY
Cutaneous Tolerance Scores: Dryness/Scaling
-0.11
PRIMARY
Cutaneous Tolerance Scores: Edema
0.00
PRIMARY
Cutaneous Tolerance Scores: Burning/Stinging
0.02
PRIMARY
Cutaneous Tolerance Scores: Itching
0.04
PRIMARY
Cutaneous Tolerance Scores: Tightness/Dry Feeling
-0.05
SECONDARY
Cutaneous Tolerance Scores: Erythema
-0.09
SECONDARY
Cutaneous Tolerance Scores: Dryness/Scaling
-0.11
SECONDARY
Cutaneous Tolerance Scores: Edema
0.00
SECONDARY
Cutaneous Tolerance Scores: Burning/Stinging
0.02
SECONDARY
Cutaneous Tolerance Scores: Itching
0.04
SECONDARY
Cutaneous Tolerance Scores: Tightness/Dry
-0.02

Summary

The study will look to evaluate the tolerance of a light therapy-based acne mask device in participants who report having sensitive skin. All participants will receive a cleanser, a light therapy mask, and an extra activator for the light therapy mask.

Eligibility Criteria

Inclusion Criteria

  • In good general health
  • Has mild to moderate facial acne
  • Has sensitive skin per sensitive skin questionnaires
  • Has score of "0" or "1" in all tolerance parameters (erythema, dryness/scaling, edema, burning/stinging, itching, and tightness/dryness feeling)
  • Able to read, write, speak, and understand English
  • Must agree to practice a medically acceptable form of birth control

Exclusion Criteria

  • Has known light or photo-sensitivity disorder
  • Has very sensitive skin or known allergies to skincare products or the cleanser ingredients
  • Has severe acne or pre-existing facial skin conditions other than mild to moderate acne
  • Females that are pregnant, nursing, or planning to become pregnant
  • Males with a female partner who is pregnant or planning to become pregnant
  • Has been using a product or medication that the investigator determines will increase health risk to the subject or confuse the study results
  • Is participating or has participated in another study with the past 30 days
  • Has history of immunosuppression/immune deficiency disorders
  • Has planned surgeries or invasive medical procedures scheduled during the study
  • Is related to the Sponsor, Investigator, or Study Site
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03128723). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search